Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of Oncology.

Authors :: Riddell SR
Greenberg PD
Overell RW
Loughran TP
Gilbert MJ
Lupton SD
Agosti J
Scheeler S
Coombs RW
Corey L
Source :: Human gene therapy [Hum Gene Ther] 1992 Jun; Vol. 3 (3), pp. 319-38.
Publication Year :: 1992

Subjects :: Adolescent
Adult
CD8 Antigens
Clinical Protocols
Combined Modality Therapy
HIV Seropositivity complications
HIV Seropositivity drug therapy
Humans
Lymphoma, AIDS-Related etiology
Lymphoma, AIDS-Related surgery
Middle Aged
T-Lymphocytes, Cytotoxic immunology
Zidovudine therapeutic use
Bone Marrow Transplantation
HIV Seropositivity therapy
Immunotherapy, Adoptive
Lymphoma, AIDS-Related therapy
T-Lymphocytes, Cytotoxic transplantation

Full Text Access

Tools